Eisai Co Ltd

4523

Company Profile

  • Business description

    Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of research and development, manufacturing, sales, import, and export of pharmaceuticals. The pharmaceutical business is categorized by region, including East Asia & Global South; Europe, Middle East, Africa, Russia, Oceania (EMEA); Americas; China; and Japan. The company also reports a consumer healthcare business for Japan. The vast majority of the company's revenue is derived from its American pharmaceutical business, followed by its Japanese pharmaceuticals segment. The company utilizes licensing strategies in order to expand its research, development, manufacturing, and marketing capabilities.

  • Contact

    4-6-10 Koishikawa
    Bunkyo-ku
    Tokyo112-8088
    JPN

    T: +81 338173030

    https://www.eisai.co.jp

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    10,543

Stocks News & Analysis

stocks

Cheap ASX share may have more room to run

Shares are cheap despite rebounding share price, yet risks remain.
stocks

ASX listed media giant drives strong earnings growth

Digital growth drives earnings beat for media share.
stocks

ASX real estate platform outperforms yet questions remain

Valuation remains a key concern despite strong August reporting.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,424.1013.30-0.14%
CAC 408,715.670.740.01%
DAX 4026,339.5920.140.08%
Dow JONES (US)54,005.9430.99-0.06%
FTSE 10010,853.0748.02-0.44%
HKSE25,937.49269.461.05%
NASDAQ26,707.3016.690.06%
Nikkei 22566,970.221,363.512.08%
NZX 50 Index13,888.2464.110.46%
S&P 5007,770.3912.750.16%
S&P/ASX 2009,232.6017.00-0.18%
SSE Composite Index3,966.5926.560.67%

Market Movers